Raynaud's Phenomenon

被引：198
作者：
Wigley, Fredrick M. [1 ]
Flavahan, Nicholas A. [2 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Div Rheumatol, 5200 Eastern Ave,Suite 4100,Mason E Lord Bldg Ctr, Baltimore, MD 21224 USA
[2] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, 5200 Eastern Ave,Suite 4100,Mason E Lord Bldg Ctr, Baltimore, MD 21224 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 375卷 / 06期
关键词：
INDUCED CUTANEOUS VASOCONSTRICTION; CALCIUM-CHANNEL BLOCKERS; SYSTEMIC-SCLEROSIS; DOUBLE-BLIND; DIGITAL ULCERS; SECONDARY; CRITERIA; THERAPY; SCLERODERMA; PREVENTION;
D O I：
10.1056/NEJMra1507638
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：556 / 565
页数：10
相关论文
共 56 条
[1]  
Abou-Raya A, 2008, J RHEUMATOL, V35, P1801
[2]  
[Anonymous], COCHRANE DATABASE SY
[3]  
Bergersen TK, 2014, CLIN EXP RHEUMAT S86, V32
[4]   Evaluation of the effect of ambrisentan on digital microvascular flow in patients with systemic sclerosis using laser Doppler perfusion imaging: a 12-week randomized double-blind placebo controlled trial [J].
Bose, Nilanjana ;
Bena, James ;
Chatterjee, Soumya .
ARTHRITIS RESEARCH & THERAPY, 2015, 17
[5]   Thumb Involvement in Raynaud's Phenomenon as an Indicator of Underlying Connective Tissue Disease [J].
Chikura, Batsi ;
Moore, Tonia ;
Manning, Joanne ;
Vail, Andy ;
Herrick, Ariane L. .
JOURNAL OF RHEUMATOLOGY, 2010, 37 (04) :783-786
[6]   Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine [J].
Coleiro, B ;
Marshall, SE ;
Denton, CP ;
Howell, K ;
Blann, A ;
Welsh, KI ;
Black, CM .
RHEUMATOLOGY, 2001, 40 (09) :1038-1043
[7]  
Denton CP, 2000, CLIN EXP RHEUMATOL, V18, P499
[8]  
Duquene PP, 2015, INT ANGIOL, V34, P467
[9]  
Dziadzio M, 1999, ARTHRITIS RHEUM-US, V42, P2646, DOI 10.1002/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO
[10]  
2-T
123456